Skip to main content
Log in

Efficacy of rifamycin SV and vancomycin againstBacteroides fragilis in vitro and in experimentally infected mice

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

The efficacy of rifamycin SV and vancomycin againstBacteroides fragilis was compared with that of metronidazole in vitro and in vivo. The in vitro comparison was based on the MIC and on short-term growth curves, the in vivo comparison on a mixed infection withB. fragilis andEscherichia coli in a thigh infection model in mice.

Rifamycin SV was about 11 times less effective than metronidazole in vivo, according to dose, and about 30 times less effective according to the mean plasma concentration. This lower efficacy could have been anticipated on the basis of the effect on in vitro grwoth curves, but not from the MIC.

Vancomycin was about nine times less effective than metronidazole in vivo according to dose and about 18 times less effective according to the mean plasma concentration. The latter difference was less than would have been predicted from the results obtained in vitro, i.e., from both the effect on the growth curves and the MIC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. Amon I, Amon K, Hüller H (1978) Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. Int J Clin Pharmacol 16:384–386

    Google Scholar 

  2. Armitage P (1971) Statistical methods in medical research. Oxford: Blackwell, pp 444–450

    Google Scholar 

  3. Bergamini N, Fowst G (1965) Rifamycin SV. Arzneimittelforsch 15:951–1002

    PubMed  Google Scholar 

  4. Dijkmans BAC, Mattie H, Hermans J, Van Furth R (1984) Quantification of the effect of anti-anaerobic drugs in experimentalBacteroides fragilis infection in mice. J Antimicrob Chemother 13:79–86

    Google Scholar 

  5. Finegold SM (1977) Anaerobic bacteria in human disease. New York: Academic Press, p 519

    Google Scholar 

  6. Kucers A (1982) Chloramfenicol, erythromycin, vancomycin, tetracylines. Lancet 1:425–429

    PubMed  Google Scholar 

  7. Leading article (1973)Bacteroides in the blood. Lancet 2:27–28

    Google Scholar 

  8. Mattie H, Goslings WRO, Noach EL (1973) Cloxacillin and nafcillin: serum binding and its relationship to antibacterial effect in mice. J Infect Dis 128:170–177

    Google Scholar 

  9. Mattie H, Vaishnav J (1983) The effect of antimicrobial drugs on the growth kinetics ofBacteroides in vitro. Curr Microbiol 8:191–194

    Google Scholar 

  10. Ralph ED, Clarke JT, Libke RD, Luthy RP, Kirby WMM (1974) Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother 6:691–696

    PubMed  Google Scholar 

  11. Sutter VL, Kwok YY, Finegold SM (1974) In vitro susceptibility testing of anaerobes: standardization of a single disc test. In: Anaerobic bacteria: role in disease. Springfield IL: CC Thomas

    Google Scholar 

  12. Tedesco F, Markham R, Gurwith M, Christie D, Bartlett JG (1978) Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 2:226–228

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dijkmans, B.A.C., Vaishnav-Nair, J. & Mattie, H. Efficacy of rifamycin SV and vancomycin againstBacteroides fragilis in vitro and in experimentally infected mice. Current Microbiology 12, 53–58 (1985). https://doi.org/10.1007/BF01567754

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01567754

Keywords

Navigation